Similar findings were observed in mouse models of breast cancers, where loss of p53 increased frequencies of circulating and tumor neutrophils through unchecked WNT signaling, resulting in enhanced metastasis (Wellenstein et al., 2019). Here, TP53 is linked to breast carcinoma.